ASCO/EHA/ICML 2023 – Anna Schuh

Anna Schuh talks about genetic aberrations in subclones in terms of the molecular dynamics of relapse in patients with CLL, the benefits of liquid biopsies as well as the current role and future application of whole-genome sequencing in precision hematology while ultimately depicting her personal highlights from this year’s EHA congress.

Here is the full ASCO/EHA/ICML 2023 report.

More posts